Close

Acceleron Pharma (XLRN) PT Raised to $171 at Citi

March 1, 2021 5:52 AM EST
Get Alerts XLRN Hot Sheet
Price: $178.75 --0%

Rating Summary:
    11 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 18 | Down: 24 | New: 19
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz raised the price target on Acceleron Pharma (NASDAQ: XLRN) to $171.00 (from $137.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change